Last reviewed · How we verify
Dexmedetomidine with ropivacaine
Dexmedetomidine with ropivacaine is a Small molecule drug developed by Aristotle University Of Thessaloniki. It is currently FDA-approved. Also known as: DR.
Dexmedetomidine with ropivacaine, developed by Aristotle University of Thessaloniki, is a marketed drug with a key composition patent expiring in 2028. The drug's primary strength lies in its unique combination of dexmedetomidine and ropivacaine, which differentiates it in the market. The primary risk is the patent expiry in 2028, which could lead to increased competition from generics.
At a glance
| Generic name | Dexmedetomidine with ropivacaine |
|---|---|
| Also known as | DR |
| Sponsor | Aristotle University Of Thessaloniki |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine (PHASE4)
- PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults (NA)
- Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults (NA)
- Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) Block (NA)
- Comparison of Anesthetic Techniques for Early Recovery After Ankle Arthroscopy (NA)
- PENG Block With Dexmedetomidine in Older Adults (NA)
- Tubeless Strategy in Lung Transplantation: A Prospective Single-Arm Study (NA)
- Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexmedetomidine with ropivacaine CI brief — competitive landscape report
- Dexmedetomidine with ropivacaine updates RSS · CI watch RSS
- Aristotle University Of Thessaloniki portfolio CI
Frequently asked questions about Dexmedetomidine with ropivacaine
What is Dexmedetomidine with ropivacaine?
Who makes Dexmedetomidine with ropivacaine?
Is Dexmedetomidine with ropivacaine also known as anything else?
What development phase is Dexmedetomidine with ropivacaine in?
Related
- Manufacturer: Aristotle University Of Thessaloniki — full pipeline
- Also known as: DR
- Compare: Dexmedetomidine with ropivacaine vs similar drugs
- Pricing: Dexmedetomidine with ropivacaine cost, discount & access